By studying amyloid and tau's interactions in vivo and changes in both brain and behavior, we can help unravel how amyloid and tau together lead to pathology seen in Alzheimer's disease. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.